TW282470B - - Google Patents

Info

Publication number
TW282470B
TW282470B TW083110599A TW83110599A TW282470B TW 282470 B TW282470 B TW 282470B TW 083110599 A TW083110599 A TW 083110599A TW 83110599 A TW83110599 A TW 83110599A TW 282470 B TW282470 B TW 282470B
Authority
TW
Taiwan
Prior art keywords
hydrogen atom
group
chem
hydroxyl group
amino group
Prior art date
Application number
TW083110599A
Other languages
English (en)
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of TW282470B publication Critical patent/TW282470B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
TW083110599A 1993-11-18 1994-11-15 TW282470B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28902093 1993-11-18

Publications (1)

Publication Number Publication Date
TW282470B true TW282470B (zh) 1996-08-01

Family

ID=17737794

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083110599A TW282470B (zh) 1993-11-18 1994-11-15

Country Status (10)

Country Link
EP (1) EP0654473B1 (zh)
KR (1) KR950014110A (zh)
CN (1) CN1041729C (zh)
AT (1) ATE184282T1 (zh)
CA (1) CA2136159A1 (zh)
DE (1) DE69420514T2 (zh)
DK (1) DK0654473T3 (zh)
ES (1) ES2138052T3 (zh)
GR (1) GR3031767T3 (zh)
TW (1) TW282470B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
AU1711599A (en) * 1997-12-19 1999-07-12 Bristol-Myers Squibb Company Prodrugs of lobucavir and methods of use
JP3709793B2 (ja) * 2001-01-29 2005-10-26 株式会社村田製作所 振動ジャイロおよびそれを用いた電子装置および振動ジャイロの自己診断方法
JP2004026695A (ja) * 2002-06-24 2004-01-29 M's Science Corp 水性点眼用製剤
GB0814065D0 (en) * 2008-08-01 2008-09-10 Univ Leuven Kath Use of nucleoside analogs as anti-koi herpes virus molecules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US4859680A (en) * 1984-04-10 1989-08-22 Merck & Co., Inc. Pyrimidine derivatives as antiviral compounds
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
CA2005815C (en) * 1988-12-19 1999-08-03 Wellcome Foundation Limited (The) Antiviral acyclic nucleoside derivatives
AU647822B2 (en) * 1990-09-14 1994-03-31 Marion Merrell Dow Inc. Novel carbocyclic adenosine analogs useful as immunosuppressants
ATE187173T1 (de) * 1991-03-05 1999-12-15 Ajinomoto Kk Cyclopropanderivat
JPH0680670A (ja) * 1992-09-03 1994-03-22 Ajinomoto Co Inc シクロプロパン誘導体及びその製造法

Also Published As

Publication number Publication date
DK0654473T3 (da) 2000-03-20
CN1111244A (zh) 1995-11-08
EP0654473A1 (en) 1995-05-24
DE69420514T2 (de) 2000-05-18
KR950014110A (ko) 1995-06-15
EP0654473B1 (en) 1999-09-08
CN1041729C (zh) 1999-01-20
GR3031767T3 (en) 2000-02-29
ES2138052T3 (es) 2000-01-01
DE69420514D1 (de) 1999-10-14
CA2136159A1 (en) 1995-05-19
ATE184282T1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
KR100202474B1 (en) Novel tetrapeptide derivative
DK0528678T3 (da) Pyrrolidylthiocarbapenemderivat med antibakteriel aktivitet
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
HUT55605A (en) Herbicide compositions containing diamino-triazine derivatives as active componentsand process for producing the active components
GR3029603T3 (en) Cytotoxic stilbene derivatives and pharmaceutical composition containing them.
HK1011967A1 (en) Amide derivatives having anti-hyper cholesteremic activity their preparation and their therapeutic uses
IL88755A (en) (1:, 2, 3:)-3-substituted-2- hydroxycyclo- butanemethanol derivatives and pharmaceutical and veterinary compositions containing the same
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
TW271435B (zh)
HK116296A (en) Amide derivatives and dermatologic preparations containing the same
NZ248099A (en) Use of spiro-oxathiolane quinuclidine derivatives for treating sjoegren syndrome
GR3020682T3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
GR3007401T3 (zh)
TW282470B (zh)
MY132057A (en) Quinoxalinones, a process for their preparation and their use
EP0350251A3 (en) N-substituted amide derivatives
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
ZA881430B (zh)
NZ334119A (en) Use of pentynoic acid derivatives as neurotrophic and antiproliferative agents
GR3007219T3 (zh)
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
HUT52044A (en) Process for producing pyrrolidine derivatives
AU4243689A (en) Antitumor substance, process for preparing the same and anticancer agent containing the same
EP0360239A3 (en) Ks-501 derivatives

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees